Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604668 · ClinicalTrials.gov registry record
Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 10
- Enrollment target
NCT01604668 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT01604668 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
There is no study hypothesis. The purpose of this study is to compare the accuracy of the: 1) SpHb (Radical 7 Pulse Co-Oximetry with SpHb™) RevF sensor (currently marketed), 2) the SpHb RevG sensor (a new, limited release version), and 3) the Pronto-7 sensor (currently marketed version) in patients undergoing spine surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01604668
The ClinicalTrials.gov registry entry for NCT01604668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01604668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01604668 about?
NCT01604668 is a clinical study titled "Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring". There is no study hypothesis. The purpose of this study is to compare the accuracy of the: 1) SpHb (Radical 7 Pulse Co-Oximetry with SpHb™) RevF sensor (currently marketed), 2) the SpHb RevG sensor (a new, limited release version), and 3) the Pronto-7 sensor (currently marketed version) in patients ...
What is the current status of trial NCT01604668?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-05. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01604668?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.